kwic
under
under
right
off
ON
209
1
100
500
strict
ELIZA cgi-bash version rev. 1.90
- Medical English LInking keywords finder for the PubMed Zipped Archive (ELIZA) -
return
kwic search for under out of >500 occurrences
321496 occurrences (No.66 in the rank) during 5 years in the PubMed. [cache]
--- ABSTRACT ---
--- ABSTRACT END ---
[frequency of next (right) word to under]
321496 occurrences (No.66 in the rank) during 5 years in the PubMed. [cache]
| 209) Calcitonin gene-related peptide receptor antagonists, such as telcagepant, have been under investigation as a treatment for acute migraine. |
| PMID:24382126 DOI:10.1111/papr.12158 |
| 2015 Pain practice : the official journal of World Institute of Pain |
| * Efficacy, safety, and tolerability of telcagepant in the treatment of acute migraine: a meta-analysis. |
| - Although triptans are widely used for treating acute migraine, they are contraindicated or not effective in a large proportion of patients. Hence, alternative treatments are needed. Calcitonin gene-related peptide receptor antagonists, such as telcagepant, have been under investigation as a treatment for acute migraine. A meta-analysis of the efficacy of telcagepant vs. placebo and triptans (zolmitriptan or rizatriptan) was performed. Randomized controlled trials were indentified from databases using the following search terms: migraine; calcitonin gene-related peptide; calcitonin gene-related peptide receptor antagonists; efficacy; safety, and telcagepant. The primary outcome measure was pain freedom 2 hours after first treatment. The secondary outcome measure was pain relief 2 hours after first treatment. Eight trials were included in the meta-analysis (telcagepant = 4011 participants). The difference in pain freedom at 2 hours significantly favored telcagepant over placebo (odds ratio = 2.70, 95% confidence interval = 2.27-3.21, P < 0.001) and triptans over telcagepant (odds ratio = 0.68, 95% confidence interval = 0.56-0.83, P < 0.001). The difference in pain relief at 2 hours significantly favored telcagepant over placebo (odds ratio = 2.48, 95% confidence interval = 2.18-2.81, P < 0.001). The difference in pain relief at 2 hours did not significantly favor telcagepant over triptans or vice versa (odds ratio = 0.76, 95% confidence interval = 0.57-1.01, P = 0.061). These findings indicate that telcagepant can be effective for treating acute migraine. Calcitonin gene-related peptide receptor antagonists represent a potentially important alternative means of treating acute migraine. |
[
right
kwic]
(1)95  the |
(18)4 these |
(35)2 axial |
(52)2 of |
| (2)13 different |
(19)3 high |
(36)2 censoring |
(53)2 optimal |
| (3)12 a |
(20)3 investigation |
(37)2 clinical |
(54)2 physiological |
| (4)9 general |
(21)3 light |
(38)2 consideration |
(55)2 pulsatile |
| (5)8 both |
(22)3 local |
(39)2 controlled |
(56)2 scanning |
| (6)8 which |
(23)3 mechanical |
(40)2 current |
(57)2 serum-free |
| (7)7 various |
(24)2 *null* | (41)2 evaluation |
(58)2 several |
| (8)6 conditions |
(25)2 12 |
(42)2 ex |
(59)2 simulated |
| (9)6 curve |
(26)2 15 |
(43)2 extreme |
(60)2 specific |
| (10)6 static |
(27)2 2 |
(44)2 four |
(61)2 steady-state |
| (11)5 and |
(28)2 CA |
(45)2 hypertensive |
(62)2 therapy |
| (12)4 5 |
(29)2 CT |
(46)2 hypoxia |
(63)2 this |
| (13)4 certain |
(30)2 H2O2-induced |
(47)2 hypoxic |
(64)2 time |
| (14)4 control |
(31)2 UV |
(48)2 inflammatory |
(65)2 treatment |
| (15)4 either |
(32)2 acute |
(49)2 laser |
(66)2 ultrasound |
| (16)4 in |
(33)2 additive |
(50)2 lateral |
(67)2 vertical |
| (17)4 normal |
(34)2 adverse |
(51)2 mortality |
(68)2 water |
add keyword
--- WordNet output for under ---